Noluthando Mwelase

Publications

18

Citations

659

h-index

11

Publishing journals

15

Years of publications

11

Active since

2014

References

422

Institutions

4

1. High recent PrEP adherence with point‐of‐care urine tenofovir testing and adherence counselling among young African women: results from the INSIGHT cohort
   Journal of the International AIDS Society, Volume 27, Issue 12, No. e26389, Pages e26389-e26389, Year 2024
2. Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester
   Clinical Infectious Diseases, Volume 78, Issue 3, Pages 667-673, Year 2024
3. Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort
   UNC Libraries, Year 2024
4. Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19
   Annals of Internal Medicine, Volume 176, Issue 5, Pages 658-666, Year 2023
5. Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings
   JAIDS Journal of Acquired Immune Deficiency Syndromes, Volume 94, Issue 2, Pages 165-173, Year 2023
6. Population Pharmacokinetic Modeling and Simulation of Rifapentine Supports Concomitant Antiretroviral Therapy with Efavirenz and Non-Weight Based Dosing
   Antimicrobial Agents and Chemotherapy, Volume 66, Issue 9, Pages e0238521-e0238521, Year 2022
7. Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine
   Pharmacogenetics and Genomics, Volume 31, Issue 1, Pages 17-27, Year 2021
8. Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention
   Journal of Antimicrobial Chemotherapy, Volume 76, Issue 3, Pages 718-721, Year 2021
9. Dolutegravir-based Antiretroviral Therapy for Patients Coinfected with Tuberculosis and Human Immunodeficiency Virus: A Multicenter, Noncomparative, Open-label, Randomized Trial
   Clinical Infectious Diseases, Volume 70, Issue 4, Pages 549-556, Year 2020
10. Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy
    JAIDS Journal of Acquired Immune Deficiency Syndromes, Volume 84, Issue 4, Pages 422-429, Year 2020
11. One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
    New England Journal of Medicine, Volume 380, Issue 11, Pages 1001-1011, Year 2019
12. As-needed vs immediate etoposide chemotherapy in combination with antiretroviral therapy for mild-to-moderate AIDS-associated kaposi sarcoma in resource-limited settings: A5264/AMC-067 randomized clinical trial
    Clinical Infectious Diseases, Volume 67, Issue 2, Pages 251-260, Year 2018
13. Dolutegravir-Based Antiretroviral Therapy for the Treatment of Patients Co-Infected with Tuberculosis and HIV: A Multicenter, Phase 3B, Noncomparative, Open-Label, Randomized Trial
    SSRN Electronic Journal, Year 2018
14. Virologic outcomes in early antiretroviral treatment: HPTN 052
    HIV Clinical Trials, Volume 18, Issue 3, Pages 100-109, Year 2017
15. Long - term trends in mortality and AIDS-defining events among perinatally HIV-infected children across Europe and Thailand
    St George's Online Research Archive (St George's University of London), Volume 19, Issue 6 Suppl 5, Pages 21264-21264, Year 2016
16. HPTN 069/ACTG A5305: phase II study of maraviroc-containing regimens for HIV PrEP in US women; Postive impact of a randomized controlled trial of the Uthando Lwethu ("Our Love") intervention on rates of couples HIV testing in rural South Africa
    Deep Blue (University of Michigan), Year 2016
17. Pre-antiretroviral therapy serum selenium concentrations predict WHO stages 3, 4 or death but not virologic failure post-antiretroviral therapy
    Nutrients, Volume 6, Issue 11, Pages 5061-5078, Year 2014
18. Pre‐antiretroviral therapy (ART) selenium status predicts HIV clinical but not virologic failure post‐ART (LB326)
    The FASEB Journal, Volume 28, Issue S1, Year 2014

No publications in the index yet.